Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors

References

• Yang J, Wu Z, Long Q, et al. Insights Into immunothrombosis: the interplay Among neutrophil extracellular trap, von willebrand factor, and ADAMTS13. Front Immunol. 2020;11:610696.
   PubMed Web of Science ®Google Scholar
• Bai Y, Xu J, Chen L, et al. Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging. 2021;48(8):2531–2542.
   PubMed Web of Science ®Google Scholar
• Cabrera Martimbianco AL, Pacheco RL, Bagattini ÂM, et al. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357.
   PubMed Web of Science ®Google Scholar
• Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737–754.
   PubMed Web of Science ®Google Scholar
• Urban CF, Ermert D, Schmid M, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5(10):e1000639.
   PubMed Web of Science ®Google Scholar
• Fagerhol MK, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Eur Physiopathol Respir. 1980(16 Suppl):273–282.
   PubMedGoogle Scholar
• Steinbakk M, Naess-Andresen CF, Lingaas E, et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990;336(8718):763–765.
   PubMed Web of Science ®Google Scholar
• Rosen T, Nolan EM. Metal sequestration and antimicrobial activity of human calprotectin are pH-Dependent. Biochem. 2020;59(26):2468–2478.
   PubMed Web of Science ®Google Scholar
• Berntzen HB, Olmez U, Fagerhol MK, et al. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 1991;20(2):74–82.
   PubMed Web of Science ®Google Scholar
• Røseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol. 1992;27(9):793–798.
   PubMed Web of Science ®Google Scholar
• Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull. 2003;26(6):753–760.
   PubMed Web of Science ®Google Scholar
• Shi H, Zuo Y, Yalavarthi S, et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. J Leukoc Biol. 2021;109(1):67–72.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999.
   PubMed Web of Science ®Google Scholar
• Boneschansker L, Inoue Y, Oklu R, et al. Capillary plexuses are vulnerable to neutrophil extracellular traps. Integr Biol (Camb). 2016;8(2):149–155.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Zuo M, Yalavarthi S, et al. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis. 2021;51:446–453.
   PubMed Web of Science ®Google Scholar
• Jiménez-Alcázar M, Rangaswamy C, Panda R, et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 2017;358(6367):1202–1206.
   PubMed Web of Science ®Google Scholar
• Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol. 2007;39(3):505–528.
   PubMed Web of Science ®Google Scholar
• Manon-Jensen T, Itoh Y, Couchman JR. Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J. 2010;277(19):3876–3889.
   PubMed Web of Science ®Google Scholar
• Svennevig K, Hoel TN, Thiara AS, et al. Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass. Perfusion. 2008;23(3):165–171.
   PubMed Web of Science ®Google Scholar
• Ogawa F, Oi Y, Nakajima K, et al. Temporal change in syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J. 2021;19(1):55.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Baxter-Parker G, Lindsay A. Neopterin, inflammation, and oxidative stress: what could we be missing? Antioxidants (Basel). 2018;7(7):80.
   PubMedGoogle Scholar
• Özger HS, Dizbay M, Corbacioglu SK, et al. The prognostic role of neopterin in COVID-19 patients. J Med Virol. 2021;93(3):1520–1525.
   PubMed Web of Science ®Google Scholar
• Nübling CM, Chudy M, Volkers P, et al. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection. Transfusion. 2006;46(11):1886–1891.
   PubMed Web of Science ®Google Scholar
• Mayersbach P, Fuchs D, Schennach H. Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting. Clin Chem Lab Med. 2010;48(3):373–377.
   PubMed Web of Science ®Google Scholar
• Okba N, Müller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2 − specific antibody responses in coronavirus disease patients. Emerg Infect Dis. 2020;26(7):1478–1488.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Nissen-Meyer LSH, Brantsaeter AB. The story of an extraordinary year: challenges and opportunities in responding to covid-19. Transfus Apher Sci. 2021;60(2):103092.
   PubMed Web of Science ®Google Scholar
• Søraas AVL. Risk factors for community- and workplace transmission of COVID-19. ClinicalTrials.gov. Identifier: NCT04320732.
   Google Scholar
• Fagerhol MK, Rugtveit J. Heterogeneity of fecal calprotectin reflecting generation of neutrophil extracellular traps (NETs) in the gut: new immunoassays are available. JMP. 2022;3(1):38–51.
   Web of Science ®Google Scholar
• Fagerhol MK, Johnson E, Tangen JM, et al. NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: a pilot study. Scand J Immunol. 2020;91(5):e12870.
   PubMed Web of Science ®Google Scholar
• Kåsine T, Dyrhol-Riise AM, Barratt-Due A, et al. Nor-solidarity study group. Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: results from the NOR-Solidarity trial. J Intern Med. 2022;291(2):241–243.
   PubMed Web of Science ®Google Scholar
• Jarlborg M, Courvoisier DS, Lamacchia C, et al. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther. 2020;22(1):105.
   PubMed Web of Science ®Google Scholar
• Fagerhol MK, Nielsen HG, Vetlesen A, et al. Increase in plasma calprotectin during long-distance running. Scand J Clin Lab Invest. 2005;65(3):211–220.
   PubMed Web of Science ®Google Scholar
• Dogné S, Flamion B. Endothelial glycocalyx impairment in disease: focus on hyaluronan shedding. Am J Pathol. 2020;190(4):768–780. Apr
   PubMed Web of Science ®Google Scholar
• Blomberg B, Mohn KG, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607–1613.
   PubMed Web of Science ®Google Scholar
• Bellmann-Weiler R, Lanser L, Burkert F, et al. Neopterin predicts disease severity in hospitalized patients With COVID-19. Open Forum Infect Dis. 2021;8(1):ofaa521.
   PubMed Web of Science ®Google Scholar
• Robertson J, Gostner JM, Nilsson S, et al. Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect Dis. 2020;20(1):942.
   PubMed Web of Science ®Google Scholar
• Grabherr F, Effenberger M, Pedrini A, et al. Increased fecal neopterin parallels gastrointestinal symptoms in COVID-19. Clin Transl Gastroenterol. 2021;12(1):e00293.
   PubMed Web of Science ®Google Scholar
• Joyner MJ, Bruno KA, Klassen SA, et al. Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc. 2020;95(9):1888–1897.
   PubMed Web of Science ®Google Scholar
• Hueso T, Pouderoux C, Péré H, et al. Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19. Blood. 2020;136(20):2290–2295.
   PubMed Web of Science ®Google Scholar